Evidence map›Paper›PMID 38650243›Full record

ArticleBioresources and bioprocessing2021

Discovery of a readily heterologously expressed Rubisco from the deep sea with potential for CO

Junli Zhang, Guoxia Liu, Alonso I Carvajal, Robert H Wilson, Zhen Cai, Yin Li

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioresources and bioprocessing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. In vivo directed evolution of an ultrafast Rubisco from a semianaerobic environment imparts oxygen resistance.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Engineering Rubisco to enhance COSynthetic and systems biotechnology · 2024
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Junli Zhang *CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Guoxia Liu *CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Alonso I CarvajalDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.
Robert H WilsonDepartment of Cellular Biochemistry, Max Planck Institute of Biochemistry, 82152, Martinsried, Germany. rhwilson@mit.edu.
Zhen CaiCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. caiz@im.ac.cn.
Yin LiCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China. yli@im.ac.cn.
Microbiology Institute of Shaanxi · CNMax Planck Institute of Biochemistry · DEState Key Laboratory of Microbial Resources

Funding

the National Natural Science Foundation of China 2150060111
6 · The paper itself

Abstract

Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), the key CO

Indexed as

CO2 capture in vivoForm IIHexamerRiftia pachyptila endosymbiontRubisco

Identifiers

PMID38650243
PMCPMC10992382
OpenAlexW3197086209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.